Ministry of Industry and Information Technology, 2017 China Pharmaceutical Industry Top 100 List

Medical Network August 6th China's top 100 pharmaceutical companies, released!

On August 4th, the 2018 (35th) National Pharmaceutical Industry Information Conference hosted by China Medical Industry Information Center opened in Shanghai. The organizer of China Medical Industry Information Center celebrated its 60th birthday. health The person in charge of the relevant departments of the State Food and Drug Administration, the State Food and Drug Administration and other relevant departments.

At the meeting, Cao Xuejun, deputy director of the Consumer Products Industry Department of the Ministry of Industry and Information Technology, introduced that the growth rate of pharmaceutical industry above designated size increased by 11% year-on-year in the first six months of this year, ranking the forefront of the national industrial industry. The main business income of enterprises above designated size increased by 13.2% year-on-year. It grew by 15.2% year-on-year, maintaining a relatively fast growth rate and a high level of profitability.

Since the beginning of this year, more than 130 domestically produced new drugs have been declared clinically, and 4 domestically produced new drugs have been approved for listing, creating the best level in the past years.

It is reported that the Department of Medicine and Health of the State Health and Welfare Commission is drafting the "Opinions on Further Improving the National Essential Drug System". The content of this review will include dynamic adjustment and optimization of the catalogue.

Li Bo, Director of the Department of Essential Drug Use Management of the Pharmacy Department of the National Health and Health Commission, who attended the meeting, introduced the shortage of reforms. drug Some measures taken by the supply guarantee mechanism. However, there is no adjustment to the list of base drugs that the industry is concerned about.

He said, 'At present, this opinion is still in the process of soliciting opinions. There is still a lot of controversy, so it is possible to share further when the next meeting is held, '

In the round-table dialogue in the afternoon, Li Song, an academician of the Chinese Academy of Engineering, talked about the topic of vaccines discussed in the previous section. He said that it is still necessary to have confidence in our country's own vaccine, and how to deal with that company.

Once the public loses confidence in the domestic vaccine, the consequences will be more serious. The national vaccine has achieved great results in these years, like hepatitis B. Our country is said to be a big country of hepatitis B, but now under 5 years old child The carrying rate of hepatitis B virus is less than 0.5%. It is the hat of the big country of hepatitis B will soon be removed, but if the immune expansion is lost once it is out of control, the consequences are very serious.

Therefore, the vaccine in our country is not inferior to the international vaccine. Chen Kaixian, an academician of the Chinese Academy of Sciences, agrees.

▍ China's top 100 pharmaceutical companies released, four pharmaceutical companies new list

The 2017 China was released at the conference. medicine Industrial top 100 enterprise List. Yangzijiang Pharmaceutical Group Co., Ltd., Guangzhou Pharmaceutical Group Co., Ltd., Amendment Pharmaceutical Group Co., Ltd. ranked in the top three.

According to the statistics and analysis of the China Pharmaceutical Industry Information Center, the top 100 companies in the 2017 annual list continued their strong growth momentum, breaking through the 750 billion mark with a growth rate of 10.2% of the main business income, although the growth rate was higher than the same period last year. The decline was 0.9 percentage points, but the growth trend remained basically stable.

It is worth noting that the threshold of the top 100 list has also increased from 2.44 billion yuan last year to 2.56 billion yuan, a slight increase of 5%. Under the leading role of the top 100 enterprises, the pharmaceutical industry is gradually moving towards economies of scale.

It is worth noting that four companies have become the new 'Top 100'.

At the meeting, it also released the Top 20 Best Industrial Enterprises in China's Pharmaceutical R&D Product Line in 2018, the Top 10 Most Growing Enterprises in China's Pharmaceutical Industry in 2018, and the Top 10 Investment Enterprises in China's Pharmaceutical Industry in 2018 (Non-listed) List, see attachment.